{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "PRE", "messageBoardId": "finmb_663087242", "regularMarketChangePercent": 3.977667, "regularMarketPrice": 14.9, "exchange": "NGM", "shortName": "iTeos Therapeutics, Inc.", "longName": "iTeos Therapeutics, Inc.", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "firstTradeDateMilliseconds": 1595597400000, "priceHint": 2, "regularMarketChange": 0.5699997, "regularMarketTime": 1684180804, "regularMarketDayHigh": 15.135, "regularMarketDayRange": "14.23 - 15.135", "regularMarketDayLow": 14.23, "regularMarketVolume": 162773, "regularMarketPreviousClose": 14.33, "bid": 0.0, "ask": 0.0, "bidSize": 11, "askSize": 8, "fullExchangeName": "NasdaqGM", "financialCurrency": "USD", "regularMarketOpen": 14.38, "averageDailyVolume3Month": 243603, "averageDailyVolume10Day": 217170, "fiftyTwoWeekLowChange": 2.3799992, "fiftyTwoWeekLowChangePercent": 0.19009577, "fiftyTwoWeekRange": "12.52 - 28.05", "fiftyTwoWeekHighChange": -13.15, "fiftyTwoWeekHighChangePercent": -0.4688057, "fiftyTwoWeekLow": 12.52, "fiftyTwoWeekHigh": 28.05, "earningsTimestamp": 1683716460, "earningsTimestampStart": 1691492340, "earningsTimestampEnd": 1692014400, "trailingAnnualDividendRate": 0.0, "trailingPE": 5.708812, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": 2.61, "epsForward": -6.26, "epsCurrentYear": -3.79, "priceEpsCurrentYear": -3.9313984, "sharesOutstanding": 35763400, "bookValue": 18.627, "fiftyDayAverage": 14.209, "fiftyDayAverageChange": 0.691, "fiftyDayAverageChangePercent": 0.04863115, "twoHundredDayAverage": 18.85315, "twoHundredDayAverageChange": -3.9531498, "twoHundredDayAverageChangePercent": -0.20968114, "marketCap": 542176704, "forwardPE": -2.3801916, "priceToBook": 0.79991406, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-07-24", "averageAnalystRating": "1.6 - Buy", "tradeable": false, "cryptoTradeable": false, "displayName": "iTeos Therapeutics", "symbol": "ITOS"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "321 Arsenal Street", "address2": "Suite 301 Building 312", "city": "Watertown", "state": "MA", "zip": "02472", "country": "United States", "phone": "339 217 0161", "website": "https://www.iteostherapeutics.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells, natural killer cells, and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.", "fullTimeEmployees": 125, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michel  Detheux Ph.D.", "age": 55, "title": "Pres, CEO & Director", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": {"raw": 922383, "fmt": "922.38k", "longFmt": "922,383"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 9797156, "fmt": "9.8M", "longFmt": "9,797,156"}}, {"maxAge": 1, "name": "Mr. Matthew A. Call M.B.A.", "age": 49, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": {"raw": 638548, "fmt": "638.55k", "longFmt": "638,548"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 3446648, "fmt": "3.45M", "longFmt": "3,446,648"}}, {"maxAge": 1, "name": "Dr. Joanne  Jenkins-Lager M.D.", "age": 50, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 639995, "fmt": "640k", "longFmt": "639,995"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 4311759, "fmt": "4.31M", "longFmt": "4,311,759"}}, {"maxAge": 1, "name": "Mr. Matthew  Gall", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Yvonne  McGrath Ph.D.", "age": 48, "title": "Chief Scientific Officer", "yearBorn": 1974, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ryan  Baker", "title": "Head of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Adi  Osovsky", "title": "VP & Head of Legal", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Phillipe  Brantegem", "title": "Vice-Pres of HR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 8, "boardRisk": 7, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}